Rheumatoid Arthritis
Dr. John Cush RheumNow
5 years ago
Kaleb Michauds study from the RA FORWARD registry shows, during the pandemic, significant medication changes (w/o MD consult) or appts. These observations show we were not prepared for this and that Rx suffered. #ACR20 Abstr#L05 https://t.co/vrDd0myGos https://t.co/JFUXItVdRQ
Here are my highlights from day three, Sunday, of the ACR 2020 Convergence.
Richard Conway RichardPAConway
5 years ago
Dr Bergman reports on PROs in RCT of upadacitinib versus abatacept in bDMARD-IR RA patients. Greater improvement in PROs with upadacitinib especially in physical functioning, pain, and general health @rheumnow #ACR20 Abstr#1728 https://t.co/NWKrhYAfZn
Dr. John Cush RheumNow
5 years ago
Smartphone T2T management of RA & SLE is possible. With over 127,316 DAS28 & 42,593 SLEDAI assessments over 2 yrs. T2T was lowest in spring for both, correlating w/ holidays in China. #ACR20 Abstr#1018 https://t.co/bGJtSTDqzo https://t.co/34za6kokOp
Eric Dein ejdein1
5 years ago
SELECT-CHOICE on UPA vs ABA in RA in NEJM Oct 2020. How about PROs? UPA wins in phys fxn, pain, general health over ABA. Abst#1728 @RheumNow #ACR20. ABA better if a safety concern, but this is more evid to go for UPA
sheila RHEUMarampa
5 years ago
#mskus findings in pt w/normal muscle volume(ABC) vs. w/sarcopenia(DEF).
This Japanese study showed US of VL muscle is useful in discriminating RA pts w & w/o sarcopenia. @RheumNow #ACR20 abs1537 https://t.co/Gv7V0eebEt
sheila RHEUMarampa
5 years ago
Accdg to this study, no association was found between IFN levels and cognitive function in SLE pts (even after considering factors like SLE dse duration)
Interesting! @RheumNow #ACR20 abs1788 @ZahiTouma https://t.co/F4j8H1CWJ9
David Liew drdavidliew
5 years ago
High-intensity interval training (HIIT) benefits RA, & it looks more than just exercise-FM-CV health.
Changes in T cell activity, muscle oxidative metabolism after HIIT in sedentary RA pts n=12
Looking forward to seeing more in this area
@dukemedicine #ACR20 ABST1757 @RheumNow https://t.co/5gKheEUYJ6
David Liew drdavidliew
5 years ago
Our RA patients are susceptible to a dangerous virus which runs rampant, but won't take the vaccine.
Why won't patients have their flu shot? @McGillMed 40% hesitant despite public funding. Multiple levels influence; if we don't address, our pts suffer!
#ACR20 ABST1740 @RheumNow https://t.co/1Yhr6I2L30
ABCs of RA: Panel Discussion with Dr. Jonathan Kay
They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.
Richard Conway RichardPAConway
5 years ago
Our @rheumnow RA panel discussion of ACR day 2 highlights is available to view #ACR20 https://t.co/3r0BwEW7eA
Gut Microbiome and RA: Dr. Robert Chao interviews Dr. Monica Guma
Dr. Monica Guma reviews her Monday abstract presentation on gut microbiome and improvement in RA (abstract #1994), being presented at the 2020 ACR annual meeting.
CV Risk in Rheumatoid Arthritis and Osteoarthritis: Dr. Eric Dein
Dr. Eric Dein reviews abstract #1189 (from the PRECISION trial) presented at the 2020 ACR annual meeting.
Hesitancy around Steroids and Vaccines: Dr. Kevin Winthrop
OHSU's Dr. Kevin Winthrop discusses two issues -- steroids and vaccines -- by looking at abstracts #1014, #0632, #0634 and #1135 at ACR 2020.
Coal Miners and RA: Dr Janet Pope
Dr. Janet Pope reviews abstract #1462 presented at the 2020 ACR annual meeting.
Poster Hall